Rothschild Asset Management Inc bought 24,022 shares in the previous quarter increasing its stake in Hill-Rom Holdings Inc (HRC) by 3.0%. Zacks Investment Research raised shares of Hill-Rom Holdings from a "hold" rating to a "buy" rating and set a $90.00 price objective on the stock in a report on Friday, October 27th. Olstein Capital Management, L.p. claims 88,780 shares with a value of $6,570,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Hill-Rom Holdings by 10.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company's stock valued at $175,000 after purchasing an additional 204 shares during the last quarter.
Dimensional Fund Advisors Lp says it sold 58,453 shares in quarter ending 09/30/2017 decreasing its holdings in Hill-Rom Holdings Inc by 6.4%. American International Group Inc controls 134,779 shares worth $9,974,000. Finally, Fox Run Management L.L.C. purchased a new stake in Hill-Rom Holdings during the 3rd quarter worth about $207,000.
Want to see what other hedge funds are holding HRC? The medical technology company reported $1.32 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.27 by $0.05, Bloomberg Earnings reports. The institutional investor owned 535,229 shares of the medical technology company's stock after purchasing an additional 424,870 shares during the quarter. The stock has a market capitalization of $5,018.79, a PE ratio of 19.74, a price-to-earnings-growth ratio of 1.62 and a beta of 1.19. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.77 and a quick ratio of 1.34. During the same quarter in the previous year, the firm posted $1.18 earnings per share. The firm had revenue of $706 million for the quarter, compared to the consensus estimate of $701.39 million. Hill-Rom Holdings had a return on equity of 20.27% and a net margin of 4.87%. (NYSE:HRC) by 4.5% during the third quarter, Holdings Channel reports. Hill-Rom Holdings updated its Q1 guidance to $0.77-0.79 EPS and its FY18 guidance to $4.22-4.30 EPS.
The firm also recently announced a quarterly dividend, which was paid on Friday, December 30th. Stockholders of record on Friday, December 15th will be paid a $0.18 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.16%. The ex-dividend date of this dividend is Thursday, December 14th. Hill-Rom Holdings's dividend payout ratio is now 36.18%.
In other news, SVP Andreas G. Frank sold 6,870 shares of the company's stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now owns 16,701 shares of the company's stock, valued at approximately $1,293,993.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
In related news, SVP Andreas G. Frank sold 3,940 shares of the business's stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total value of $306,689.60.
HRC has been the subject of several research analyst reports. On July 30 Stifel Nicolaus held the company rating at "Buy" projecting a price of $84.00.
Separately, Zacks Investment Research lowered Hill-Rom Holdings from a "buy" rating to a "hold" rating in a research note on Wednesday, November 9th. KeyCorp reaffirmed a "buy" rating and set a $89.00 price target (up previously from $82.00) on shares of Hill-Rom Holdings in a research note on Sunday, November 5th. Stifel Nicolaus raised the price target on November 6 boosting the projection from $84.00 to $85.00 with a rating of "Buy".